Covered recipient · General Payments record
CANDICE NICOLE BLACKWOOD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$507.86
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $299.11 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $102.33 | 5 |
| Acerta Pharma LLC | $67.39 | 4 |
| PFIZER INC. | $47.70 | 2 |
| Lilly USA, LLC | $35.09 | 2 |
| GlaxoSmithKline, LLC. | $18.97 | 1 |
| Amgen Inc. | $14.15 | 1 |
| Exact Sciences Corporation | $13.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.15 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117508780 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.45 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105802151 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.86 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105526061 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.19 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104213439 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.89 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104253525 | CMS |
| Exact Sciences Corporation | $13.48 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114537646 | CMS |
| GlaxoSmithKline, LLC. | $18.97 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116307211 | CMS |
| Lilly USA, LLC | $16.94 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135596526 | CMS |
| Lilly USA, LLC | $18.15 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135554744 | CMS |
| Novo Nordisk Inc | $20.01 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100303229 | CMS |
| Novo Nordisk Inc | $18.70 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100633751 | CMS |
| Novo Nordisk Inc | $22.42 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100252808 | CMS |
| Novo Nordisk Inc | $17.50 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100527357 | CMS |
| Novo Nordisk Inc | $23.70 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100329906 | CMS |
| PFIZER INC. | $18.20 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130971347 | CMS |
| PFIZER INC. | $29.50 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131691612 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.